Collaboration will Target a Therapeutic Approach for Treating Asthma and Allergic Diseases NEW YORK, Nov. 26, 2019– Hoth Therapeutics, Inc. (NASDAQ: HOTH), (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological […]
New preclinical data using a humanized mouse model confirms and expands on the potential use of leronlimab in treating this inflammatory syndrome, a common precursor to NASH VANCOUVER, Washington, Nov 21, 2019 — CytoDyn Inc. […]
Company accelerates with sign up of new AR ecomm customers NEW YORK and TORONTO, Nov 21, 2019 — NexTech AR Solutions (NexTech) (otcqb:NEXCF) (NTAR)(N29), the leader in augmented reality for e-commerce and AR learning applications, […]
TARRYTOWN, NY, Nov. 20, 2019– Nightfood, Inc. (otcqb:NGTF), the award-winning ice cream company addressing America’s $50 billion-dollar nighttime snacking problem, yesterday received confirmation that sleep-friendly Nightfood ice cream will soon be made available in a […]
CytoDyn will file for expanded access IND for patients with pancreatic, prostate, lung, breast, liver and melanoma cancers VANCOUVER, Washington, Nov 19, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology […]
One-of-a-kind, transformative technology for retailers combines messaging and AR experiences NEW YORK and TORONTO, Nov 19, 2019– NEW YORK and TORONTO, Nov. 19, 2019 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29), the […]
NEW YORK, Nov. 18, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]
Augmented reality (AR) is set to change the way organizations compete in the transportation industry NEW YORK and TORONTO, Nov 14, 2019 — November 14, 2019 – NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) […]
NEW YORK, Nov. 14, 2019 — Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“HOTH” or the “Company”), a biopharmaceutical company focused on developing new generation therapies for dermatological disorders such as atopic dermatitis, chronic wounds, psoriasis and acne, […]
VANCOUVER, Washington, Nov. 12, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today it has […]
Breakthrough Therapy designation filing possible if more patients show similar positive results VANCOUVER, Washington, Nov. 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 […]
NexTech’s ARitize v3.0, Raises The Bar on Photo Realistic WebAR 3D/AR experiences TORONTO, Nov. 12, 2019 — NexTech AR Solutions (the “Company” or “NexTech”) (otcqb:NEXCF) (NTAR)(N29) NexTech AR Solutions, the industry leader in augmented reality, […]
– Total Revenue Grew by 14% Y-O-Y Driven by Continued Growth in Consulting Services and Products with Success Nutrients and The Big Tomato- Company Strategy Fortified Through Seven Additional Pending Acquisitions to Become One of […]
Study seeks to prove that Hoth’s and Zylo’s proprietary AEA-loaded Z-pods(TM) inhibits the development of CLE lesions in a standard animal model of lupus NEW YORK, Nov. 6, 2019 — Hoth Therapeutics, Inc.(NASDAQ: HOTH) (“HOTH” or […]
DENVER, Nov. 7, 2019– Medicine Man Technologies, Inc. (otcqx:MDCL) (“Medicine Man Technologies” or the “Company”), announced today that it will host a conference call to discuss operational and financial highlights from its third quarter 2019 on […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
